OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression
Hanzhang Zhu, Weijiang Zhou, Yafeng Wan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12061-12061
Open Access | Times Cited: 6
Hanzhang Zhu, Weijiang Zhou, Yafeng Wan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12061-12061
Open Access | Times Cited: 6
Showing 6 citing articles:
High prevalence of CD44 and its ligand low molecular weight hyaluronan in plasma of HNSCC patients: clinical significance
Rituparna Sinha Roy, Nilanjana Chatterjee, Md Sadi Khan, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 3
Rituparna Sinha Roy, Nilanjana Chatterjee, Md Sadi Khan, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 3
Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential
Emilia Alors‐Pérez, Sergio Pedraza‐Arévalo, Ricardo Blázquez‐Encinas, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 8
Emilia Alors‐Pérez, Sergio Pedraza‐Arévalo, Ricardo Blázquez‐Encinas, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 8
Prognostic effect of programmed cell death ligand 1/programmed cell death 1 expression in cancer stem cells of human oral squamous cell carcinoma
Keita Todoroki, Yushi Abe, Katsuhisa Matsuo, et al.
Oncology Letters (2024) Vol. 27, Iss. 2
Open Access | Times Cited: 1
Keita Todoroki, Yushi Abe, Katsuhisa Matsuo, et al.
Oncology Letters (2024) Vol. 27, Iss. 2
Open Access | Times Cited: 1
Oncogenic CD44 is required for pancreatic cancer cell tumorigenesis and CD44 gene knockout is a new strategy for targeted pancreatic cancer therapy
Quansheng Zhou, Yuxi Liu, Mei Meng, et al.
Research Square (Research Square) (2024)
Open Access
Quansheng Zhou, Yuxi Liu, Mei Meng, et al.
Research Square (Research Square) (2024)
Open Access
Genome-scale activation screen reveals lncRNA HNF1A-AS1 as a novel therapeutic target for pancreatic cancer metastasis
Shan Lei, Zhixue Zhang, Zhirui Zeng, et al.
Research Square (Research Square) (2024)
Closed Access
Shan Lei, Zhixue Zhang, Zhirui Zeng, et al.
Research Square (Research Square) (2024)
Closed Access
Heparin-binding of the human chitinase-like protein YKL-40 is allosterically modified by chitin oligosaccharides
Unnur Magnusdottir, Finnbogi R. Thormodsson, Lilja Kjalarsdottir, et al.
Biochemistry and Biophysics Reports (2024) Vol. 41, pp. 101908-101908
Closed Access
Unnur Magnusdottir, Finnbogi R. Thormodsson, Lilja Kjalarsdottir, et al.
Biochemistry and Biophysics Reports (2024) Vol. 41, pp. 101908-101908
Closed Access
